|
期刊名称：EUROPEAN JOURNAL OF IMMUNOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
The European Journal of Immunology is an international journal focusing on the various aspects of immunological research. One of the world's leading journals of immunology, it reports on the latest breakthroughs in the area. The European Journal of Immunology is a well-respected, high-impact publication with the best Executive Committee in the field. Top authors have submitted their best papers to the journal for many years, therefore building a high quality immunology journal. An ever-increasing amount of papers is being published from top authors from all over the world. The European Journal of Immunology is committed to publishing excellence with a focus on originality, topicality, and speed of publication.
Print ISSN: 0014-2980
Online ISSN: 1521-4141
2004. Volume 34.
12 issues per year.
Language of Publication: English
Aims and Scope
HIGHLIGHTS 2009
Frontline articles: the “hottest?research published with priority
More Viewpoints: experts voice their opinions on key immunology topics
Regular Reviews and Commentaries place research in a broader context
Rapid peer review and a fast track option available for authors
International team of editors
News and EFIS: promoting immunology globally
ISSN: 0014-2980 (print), 1521-4141 (online)
Volume 39. 12 Issues in 2009. |
Instructions to Authors
Instructions to Authors
The European Journal of Immunology publishes papers focusing on various aspects of immunological research: antigen processing, cellular immune
response, immunity to infection, immunomodulation, innate immunity, molecular immunology, leukocyte signalling, clinical immunology, and new
technology. Purely descriptive studies detailing changes in gene expression profiles without any further significant investigation into the mechanisms/
mechanistic consequences of the altered expression, even if technically challenging/well performed, are not considered by the European Journal of
Immunology for publication. This policy builds on that established by the Journal for studies into peptides, T cell recognition and amino acid sequences
of gene products that are not novel but only allelic variations and that have not been linked to substantial progress in analytical insight. Again, such
studies are not considered for publication. Our Early View online publication is updated weekly and enables papers to be available online and citable
within a month of acceptance.
Authors are requested to follow these instructions carefully. Manuscripts
that are not in accordance with these instructions will be returned to
authors and this will inevitably lead to a delay in the editorial processing of
the manuscript.
Reviewing process and Fast Track Publication
All papers are assessed initially by members of the Executive Committee.
Authors should indicate, in the appropriate section during online
submission, two of the journal’s Executive Committee whose area of
expertise is closest to the topic of the paper:
Authors can also request that specific Executive Committee members be
excluded from processing their manuscript.
Following an initial assessment, those papers with a high priority rating are
sent for external review to experts in the field. Those papers with very high
priority (Frontline articles, see next paragraph) are externally reviewed with
priority. To aid in the peer review, we invite authors to suggest potential
reviewers for their paper (including address and e-mail) during the online
submission procedure. Authors also have the option of naming nonpreferred
reviewers. Those manuscripts failing to reach the required priority
rating or not fitting within the scope of the Journal are not considered further
and are returned to authors without detailed comments.
The journal offers a fast review and priority publication track for
research articles presenting superior novel findings and for studies of
greatest priority ranked against similar submissions. These ‘‘Frontline’’
articles appear earlier than regular papers. Authors can request
consideration of their manuscript for this fast track service by selecting
the manuscript type ‘Frontline: Regular Article?or ‘Frontline: Short
Communication?during online submission. The reasons for requesting
fast track processing must be detailed in the cover letter (see below). The
Executive Committee will determine whether Frontline and fast track
processing are warranted during the initial assessment of the manuscript.
Frontline status and priority publication may also be awarded following its
recommendation by the external reviewers.
Submission of manuscripts
The European Journal of Immunology uses a web-based manuscript
submission and peer review system. This service guarantees fast and
safe submission of manuscripts and a rapid assessment process. Usage
of this system is obligatory.
To submit your manuscript online, please proceed along the following
steps:
Prepare your manuscript and illustrations in the appropriate format,
according to the instructions given below. Please also make sure that
your paper conforms to the scientific and style instructions of the
European Journal of Immunology as given herein.
If you have not already done so, create an account for yourself
in the system at the submission site http://mc.manuscriptcentral.com/
eurjimmu/ by clicking on the ‘‘Create an Account’’ button. To monitor
the progress of your manuscript throughout the review process, just
login periodically and check your Author Center.
Please be sure to study the ‘‘Instructions and Forms’’ given on the
journal homepage carefully, and then let the system guide you through
the submission process. Online help is available to you at all times
during the process. You are also able to exit/re-enter at any stage
before finally ‘‘submitting’’ your work. All submissions are kept strictly
confidential. If you have any questions concerning the online
submission program, do not hesitate to contact the editorial team
(ejied@wiley-vch.de).
All submissions will be converted to PDF format during the upload
process. The system automatically generates one PDF file which
contains all parts of the manuscript.
Cover letter
Manuscripts must be accompanied by a cover letter from the corresponding
author. By submitting this letter, the corresponding author accepts responsibility
for all statements contained within it. The letter must detail the aim of
the study, the novel results obtained and how the study advances our
knowledge in no more than 250 words. The cover letter should not merely
repeat the Abstract of the manuscript but should clearly and accurately
describe the significance of the study for those working within/outside the
field. Bullet points are a recommended way of communicating this information.
Authors requesting fast track processing i.e. submitting either a ‘Frontline:
Regular Article?or ‘Frontline: Short Communication?must also detail why
the study warrants rapid review and publication, explaining the study’s
superior significance for the immunological community. Every cover letter
must also contain clear statements covering all the following points:
1) All authors concur with the submission.
2) All funding for the studies in the manuscript, together with the names of
the principal funding recipients, are listed in the Acknowledgements.
3) All persons cited in the manuscript by way of the Acknowledgements,
personal communications, unpublished observations/data concur with
the citation. Any data cited in the manuscript that has been generated
by persons not listed as authors, i.e. personal communications, must
be accompanied by a written permission letter from the person cited.
Permission letters e-mailed to ejied@wiley-vch.de are acceptable.
4) The work has not been published elsewhere, either completely, in part,
or in another form.
5) The manuscript has not been submitted to another journal and will not
be published elsewhere within one year after its publication in this
journal.
6) The manuscript does/does not contain experiments using animals. The
permission of the national or local authorities (giving the permission or
the accreditation no. of the laboratory and of the investigator) should be
stated if animal experiments are included. If no such rules or permissions
have been implicated in the particular country, this must be stated.
7) The manuscript does/does not contain human studies. If such studies
are included, it should be stated that local Ethical Committee approval
was received for the studies and that the informed consent of all
participating subjects was obtained.
Permission statements relating to points 6 and 7 should also be
included in the text of the manuscript.
8) Any financial/commercial conflicts of interests have been disclosed.
Such conflicts should be detailed in the covering letter and stated in the
manuscript after the Acknowledgements.
9) Any papers by the authors that are under consideration or in press with
other journals and not yet available online and are related to the
manuscript submitted to the European Journal of Immunology have
been submitted as supporting information.
Format and style
Manuscripts should be submitted in English. American or British spelling can
be used provided that only one spelling style is consistently used throughout.
Instructions to Authors
M. Colonna
A. Fischer
R. Fo?rster
M. Goldman
R. T. Gazinelli
D. Gray
R. Holmdahl
Hans-Martin Ja¨ck
S. Jalkanen
F. Y. Liew
B. Malissen
A. Mantovani
A. McMichael
P. S. Ohashi
P. Ricciardi-Castagnoli
T. Saito
Manuscripts must be typewritten with double spacing throughout (i.e.
including references, Tables, legends, etc.) using a page setup that leaves
margins of 3.5 cm on all sides. For essential information on preparing
manuscripts, please see the section ‘Guidelines for the preparation of electronic
data?
The first page of an article should contain only the following:
1) Title of the paper containing the most important key words pertaining to
the subject matter. The title must accurately reflect the contents of the
manuscript. The maximum length of a title is 150 characters including
spaces.
2) Full names (including forenames) of the authors and the name of their
institute(s). Surnames should be indicated by underlining. Middle
names should be indicated by initials only. If the publication originates
from several institutes the affiliation of all authors should be clearly
stated. Superscript numbers should be used to indicate affiliations.
3) Key words (3 to 5).
4) Name and full postal address of the author to whom all correspondence
(including galley proofs) is to be sent. This should include fax and
telephone numbers, and e-mail address.
5) A list of abbreviations used, excluding our standard abbreviations
(listed below). If a non-standard abbreviation is used three or more
times in the text it should be included in the list and defined the first
time it is used in the Abstract and in the main text. If it is used less than
this it should be defined in full each time it is used.
6) Any details regarding joint first authors, additional addresses, etc.
These should be linked to the author’s name by asterisks (single,
double etc. as appropriate). Please note that funding sources should
be included in the Acknowledgements section.
Two types of research articles are considered for publication (i) full length
articles and (ii) short communications. Articles of either type whose
importance ranks in the top 5?0% of the studies published in the journal
will be included in the Highlights section.
Full length articles
Full length research articles should be as concise as possible. Full length
articles of up to 7 printed pages will be published free of charge; for papers
exceeding that length a page charge of EUR 188 1 VAT per additional
page will be levied. Seven printed pages are roughly equivalent to an article
of 5000 words in total (including references and Figure legends) and
containing no more than 4 to 5 display elements (Figures and Tables).
Longer manuscripts will be considered but only if the increased length is a
reflection of the amount of data presented and not a reflection of the
inclusion of unnecessary information. Please note that the length of an
article depends greatly on the type of Figures and Tables provided.
Full length articles should be divided into the following sections and order
(please note that a combined Results and Discussion section is not
permitted for full length articles):
Summary: must not exceed 200 words and must be self-explanatory and
intelligible without reference to the text. Any citations should be written in full.
1. Introduction containing a description of the problem under
investigation and a brief survey of the existing literature on the subject.
2. Results. Full statistical analysis should be performed. The name of
each test used and its outcome should be detailed, as should the
number of samples, replicates and data presentation (SD vs SEM).
3. Discussion that enriches but does not repeat Section 1 or 2.
4. Materials and methods. For special materials and equipment, the
manufacturer’s name and, if possible, location should be provided.
Acknowledgements Finding for the research presented in the article
should be detailed in this section.
Conflict of interest. All financial and commercial conflicts of interest should
be disclosed. If there are none, this should be stated.
References (see below).
Subdivisions of sections should be indicated by subheadings. Subheadings
should be no more than 100 characters long including spaces.
Figure legends and Tables (in this order) should be given at the end of
the text file.
Supporting Information is permitted and will be published online on the
Journal’s website (www.eji-journal.eu). Such material should be clearly
referenced in the article. Please note that Supporting Information is not
edited but is posted online as received and should be submitted as a
single PDF file.
Short Communications
Short Communications should describe a significant immunological
discovery in brief. Short communications are recommended to be no more
than 3000?500 words in length (including references and Figure legends)
and contain no more than 3 display elements (Figures and Tables). Short
communications of up to 5 printed pages will be published free of charge;
for papers exceeding that length a page charge of EUR 188 1 VAT per
additional page will be levied. The sections and order of the manuscript are
as for full length articles but the Results and Discussion should be
combined and followed by a short section entitled Concluding Remarks.
Subdivisions (indicated by subheadings) within the combined Results and
Discussion section are required. Subheadings should be no more than 100
characters long including spaces.
Letters to the editor
The editorial team welcomes brief letters providing feedback on articles
published in the European Journal of Immunology. Such letters will be
reviewed by the Executive Committee of the Journal and selected letters
will be published, together with a response from the author of the
manuscript under discussion. Letters may be subject to peer-review.
Colour Figures included in this section are subject to the same charges as
such Figures in research articles.
Mini-reviews
Suggestions for mini-reviews (approx. 3000 words and 50 references) can
be e-mailed to the editorial office (ejied@wiley-vch.de).
References
References should be numbered sequentially in the order in which they
appear in the text. Citations in the Abstract are discouraged but,
if included, should be written in parentheses in accordance with the
following example (Bosco, N. et al., Eur. J. Immunol. 2008. 38: 3250-
3259.) If a reference only appears in a Table or Figure legend, and not in
the text, it should be numbered consecutively following on from the last
citation in the text. The numbers should be set in square brackets in both
the text and the reference list to ensure accurate typesetting. Titles of
journals should be abbreviated according to Index Medicus Journal
Abbreviations. A maximum of 8 authors can be listed for a reference. For
those references with more than 8 authors, list the first 7 and then et al.
The full title of the article as well as first and last page numbers should be
given, as should the DOI (Digital Object Identifier) if available and if no
print reference is available. Please note the following examples.
Journals:
Rammensee, H.-G., Friede, T. and Stevanovic, S., MHC ligands and
peptide motifs: first listing. Immunogenetics 1995. 41: 178?28.
Baggiolini, M. and Dahinden, C. A., CC chemokines in allergic inflammation.
Immunol. Today 1994. 15: 127?33.
Stadler, M. B., Arnold, D., Frieden, S., Luginbu?hl, S. and Stadler, B. M.,
Single nucleotide polymorphisms as a prerequisite for autoantigens. Eur.
J. Immunol. 2005 DOI 10.1002/eji.200425481.
Other serial publications such as "Advances in Immunology" should be
cited in the same manner as journals.
Books:
Sambrook, T., Fritsch, E. F. and Maniatis, T. (Eds.) Molecular cloning:
a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring
Harbor 1989.
Goldstein, I. M., Complement: biologically active products. In Gallin, J. I.,
Goldstein, I. M. and Snydermann, R. (Eds.) Inflammation: basic principles
and clinical correlates. Raven Press, New York 1988, pp 55?4.
Allusions to "unpublished observations", papers "to be published" or
"submitted for publication" and the like should be a part of the text, in
parentheses. Material "in press" should be entered under references.
Website addresses must not be included as a reference but should be
inserted in the text directly after the data to which they refer. The
responsibility for the accuracy of bibliographic references rests
entirely with the author.
Tables
Tables with suitable captions at the top and numbered with Arabic
numerals should be collected at the end of the text on separate sheets
(one page per Table). Tables should be provided in an editable format i.e.
in Word or Excel and not as graphic files pasted into Word. The Tables
should be understandable without frequent reference to the text. Column
headings should be kept as brief as possible and indicate units if appropriate.
Footnotes to Tables should be marked with a) b) c) etc. and typed
on the same page as the Table.Figures
Figures should be numbered in the order of their appearance in the text
with Arabic numerals. Each Figure must have a separate legend, which
should be self-explanatory and allow readers to understand the data
presented without reference to the main text. The legends should explain
all symbols, values etc used in the Figures. The legends should not appear
under the figures, but be gathered in a separate section (Figure legends)
after the references. Figures should be submitted on separate pages at the
end of the article (new page for each complete Figure). The responsibility
for providing permissions to reprint Figures and Tables and any
associated costs rests entirely with the author.
Coloured figures can only be printed if the author is prepared to pay the
cost incurred (EUR 595 for one Figure, 990 for two, 1485 for three and
1980 for four including VAT).
For essential information on preparing Figure files, please see the section
‘Guidelines for the preparation of electronic data? subheading ‘Figures?
Revised manuscripts
Revised manuscripts should be returned as follows: a text file in which all
alterations are clearly marked and visible on screen should be submitted
to MsCentral. Use either (1) the track change mode in Word or (2) change
the script colour of areas containing the required alterations. Please also
supply a clear (non-highlighted version) that can be used for production
purposes. The revised manuscript should be accompanied by a point-bypoint
letter summarising how you have dealt with each of the reviewers?BR>remarks. It is helpful to include in full the original comments of the referees
in the point-by-point reply.
Pre-submission English-language editing
Authors for whom English is a second language may choose to have their
manuscript professionally edited before submission to improve the
English. Independent suppliers of editing services include:
www.asiascienceediting.com
www.biomeditor.com
www.biosciencewriters.com
www.bluepencilscience.com
www.bostonbioedit.com
www.documentclinic.com
www.genedits.com
www.internationalscienceediting.com
www.journalexperts.com
www.oleng.com.au
www.prof-editing.com
www.sci-edit.com
www.scientific-editor.com
www.writescienceright.com
Japanese authors can also find a list of local English improvement
services at http://www.wiley.co.jp/journals/editcontribute.html.
All services are paid for and arranged by the author, and use of one of
these services does not guarantee acceptance or preference for
publication. Please note that we at Wiley have not used these services
and thus cannot attest to the quality of their work.
Guidelines for the preparation of electronic data
Text
The main text (incl. front material) as well as Figure legends and tables (in
this order) should be provided in one file, preferably saved in DOC or RTF
format.
Data should be typed unjustified, without hyphenation except for
compound words. Use carriage returns only to end headings and
paragraphs; spacing will be introduced by the typesetter.
Do not use the space bar to make indents; where these are required
(e.g., Tables) use the TAB key.
If working in Word for Windows, please create special characters
through Insert/Symbol.
Figures
For initial submission, it is not necessary to submit graphics with high
resolution; however, if your manuscript is accepted, high resolution
graphics will be required as detailed in this section.
Crop, or scale, art to the size intended for publication; no enlargement
or reduction should be necessary. If this is not possible, Figures should
be submitted in a format which can be reduced to publication size i.e. a
width of 55?5mm or 120?75 mm.
Figure panels should be indicated by capital letters (A, B, C etc).
As far as possible, all comparable labels should have the same size
lettering, and the font size should be consistent throughout the
Figures. Use standard fonts such as Times, Times New Roman,
Arial and Helvetica. Symbols and labels should be a height of
1.5?.0mm at their final published size.
Make sure that any labelling is legible against the background, and that
lines are of a suitable thickness. The recommended minimum line
weight is 0.3 pt for black lines on a light background, and 0.4 pt for white
lines on a black background; do not define lines as ‘hairline?width.
Gridlines are not allowed except for log plots.
Remove excess space and elements from around the image. Type,
lines or other elements not intended for publication should be removed
before submission.
Make the image orientation the same as that intended for publication.
Flatten images prior to submission, i.e. they should not contain layers
and/or transparent objects.
Figures should preferably be in TIFF or PPT format. Most artwork
packages can ‘Save as...?or ‘Export...?images as TIFF files. This is
preferable to saving in the native format of that programme.
Figures supplied electronically should have the following resolution at
their final published size:
Type Resolution
Graphs 800?,200 DPI
Photos 400?00 DPI
Colour (only CMYK) 300?00 DPI
Do not use higher resolutions than those given in the Table above as
these will not improve the quality of your image but will produce very
large files.
An easy way to check the quality (resolution) of Figures files is to use
the zoom function; if an image is viewed at 400% on screen and is
blurry (pixellated) then the image is probably not of high enough
resolution and will not reproduce well in print. An image viewed at
100% on screen may look fine but will not necessarily reproduce well.
This is a result of screen resolution being much lower (only 72?6 dpi)
than that of a printing press.
Changing the size of a digital image changes the resolution; however,
as the area is increased the overall dpi actually remains the same. As
an example, a photographic image that is 75mm (approx. 3 inches)
across at final size should be saved as TIFF with a width of 900 pixels
(final size: 75mm (3 in) resolution: 300 dpi). If the size is increased to
150mm (6 in), a width of 1800 pixels would be required to obtain a
resolution of 300 dpi.
Images (photos) with lettering should be saved at a higher resolution
(minimum 600 dpi) than a photographic image alone (minimum
400 dpi) to avoid the text and line art appearing jagged.
Photographic images often produce very large files; however, most
software has an option to compress the file using LZW compression
and this will produce smaller files, especially when the image contains
large areas of single colour or repeating textures and patterns.
Keeping an image simple is the best way to produce good output. Try
to avoid adding more to your graph or illustration than is necessary.
Avoid 3D charts, excessive shading, stipples, lines and symbols
(if there are several symbols, try and add them to the legend rather
than a key). When using shades of grey or other tints, be wary of using
shades too close together ?an ideal separation is 20%.
Remember that supplying high-quality electronic artwork can reduce
delays in production time as it minimizes the need for artwork to be
resupplied.
Image manipulation
Manipulation of images is strongly discouraged and all figures must
accurately reflect the original data. Information should not be enhanced,
eliminated, added, obscured or moved. In cases where manipulation is
unavoidable, this should be clearly detailed in the Figure legend. All
instruments, software and processes used to obtain the images must be
fully detailed in the manuscript either in the Figure legends or the
Materials and Methods. Acceptable image manipulation includes
uniformly adjusting the contrast of an entire image, and any controlimages, ensuring that all original data, including the background, remains
visible and that no new features are introduced. Cropping of gels, or repositioning
of lanes/fields, is permitted providing that all alterations are
clearly indicated by the use of dividing lines in the image itself, vital data
are not removed and an explanation of the alterations is included in the
Figure legend. Unacceptable manipulation includes, but is not limited to,
the enhancement of one feature/band over others, removal of background
noise/bands and so on. Authors must be able to produce all data in their
raw format upon editorial request.
Proofs and Reprints
Proofs will be sent as a low-resolution PDF file by e-mail together with a
reprint order form. The proofs should be returned to proofs-eji@macmil
lansolutions.com within 48 hours. The reprint form should be returned to
the editorial office (Fax: 149 6201 606172; ejied@wiley-vch.de), even if no
reprints are required.
Online Open
Wiley is now offering an Online Open service for authors of journal articles
whose funding agency requires deposit of an article in an archive. Authors
have the option of paying a fee to ensure that their articles are available to
non-subscribers upon publication via Wiley InterScience (http://www.
interscience.wiley.com), Wiley’s online publishing platform, as well as the
author’s funding agency’s preferred archive if applicable. Only authors of
primary research articles qualify for this service. Wiley will deposit the final
PDF of the article into the funder’s archive; this is the final, authoritative
version of the article after peer review, editing, any final corrections, online
and print formatting, and publication. The fee for ensuring articles are made
available through the funded access program is $3,000 USD per article.
Authors who are interested in finding out more about this service, or who
wish to include their article in the funded access program, are asked to go to
http://www3.interscience.wiley.com/authorresources/onlineopen.html
for further information and an order form containing payment information.
Questions can be e-mailed (fundedaccess@wiley.com).
NIH Public Access Mandate
The European Journal of Immunology is fully compliant with NIH
requirements and Wiley-Blackwell will, as a service to its authors, upload
all required files to PubMedCentral. You, as an author, do not need to
upload any files. For further information, please visit www3.interscience.
wiley.com/aboutus/open_access_options.html]NIH_mandate
Howard Hughes Medical Institute authors
The Howard Hughes Medical Institute (HHMI) and Wiley-Blackwell have
agreed to make post-peer reviewed author manuscripts of articles funded
by HHMI publicly available six months following final publication. This
policy will be implemented for those articles published after October 1,
2007. This arrangement requires nothing of the grantee; identification
and deposit are the responsibility of the publisher.
Further information can be found at www3.interscience.wiley.com/
aboutus/open_access_options.html]Howard_Hughes
Wellcome Trust authors
Please see the information in the section ‘Online Open? a service that
enables authors to comply with the Wellcome Trust funding requirements
regarding publication access. Further information can be found at www3.interscience.
wiley.com/aboutus/open_access_options.html]Wellcome_Trust
Publishing misconduct
All instances of publishing misconduct, including, but not limited to,
plagiarism, data fabrication, image/data manipulation to falsify/enhance
results etc. will result in rejection/retraction of the manuscript. Furthermore,
the corresponding author’s home institution and funding agency will
be informed of the malpractice.
COPE
This journal endorses the COPE (Committee on Publication Ethics)
guidelines and will pursue cases of suspected research and publication
misconduct (e.g. falsification, fabrication, plagiarism, inappropriate image
manipulation, redundant publication). In such cases, the journal will follow
the processes set out in the COPE flowcharts (http://publicationethics.org/
flowcharts).
Sharing of materials
All materials and reagents that are not commercially available (antibodies,
cell lines, constructs etc.) and associated protocols detailed in manuscripts
published in EJI are to be freely available to academic researchers
in a timely manner upon request. The authors agree to this condition by
submitting a manuscript to EJI.
Data requirements
Statistical analysis - standard requirements
Full statistical analysis of your data should be detailed in the manuscript,
preferably in the Figure legends to allow each Figure to be easily understood
without reference to the main text of the article. The name of each statistical
test used and the results obtained (including a description of the
comparisons made to obtain the p values, if not clearly indicated in the
Figures themselves) should be stated. The number of samples, experiments,
replicates etc. should be detailed; data presentation (mean 7 SD or
SEM etc) should be noted. Authors are encouraged to analyse data across
multiple experiments, if at all possible, and should note that analysing
replicates within a single experiment does not provide information regarding
experimental reproducibility.
Flow cytometry
Flow cytometry experiments should be MIFlowCyt (Minimum Information
about a flow cytometry experiment) compliant. See www.isac-net.org
(in particular the documents www.isac-net.org/media/standards/miflowcyt/
MIFlowCyt_080221.pdf and www.isac-net.org/media/standards/miflowcyt/
latest.pdf), http://flowcyt.sourceforge.net/ or www.mibbi.org/ for further
information.
Nucleotides
New nucleotide data must be submitted and deposited in the DDBJ/
EMBL/GenBank databases and an accession number obtained before the
paper can be accepted for publication. Submission to any one of the three
collaborating databanks is sufficient to ensure data entry in all. The
accession number should be included in the manuscript. If requested the
database will withhold release of data until publication.
Database contact/submission information:
EMBL: e-mail: datasubs@ebi.ac.uk
http://www.ebi.ac.uk
http://www.ebi.ac.uk/embl/Submission/webin.html
http://www3.ebi.ac.uk/Services/Sequin
GenBank: e-mail: info@ncbi.nlm.nih.gov
http://www.ncbi.nlm.nih.gov
http://www.ncbi.nlm.nih.gov/Banklt/
http://www.ncbi.nlm.nih.gov/Sequin/
DDBJ: e-mail: ddbj@ddbj.nig.ac.jp
http://www.ddbj.nig.ac.jp
http://sakura.ddbj.nig.ac.jp/
Proteins
Protein sequences, which have been determined by direct sequencing of
the protein, must be submitted to SWISS-PROT at the EMBL Outstation ?BR>The European Bioinformatics Institute. Results from characterization
experiments should also be submitted to SWISS-PROT at the EBI. This
can include such information as function, subcellular location, subunit etc.
Database contact/submission information:
e-mail: datasubs@ebi.ac.uk (for sequence submissions);
update@ebi.ac.uk (for characterization information)
http://www.ebi.ac.uk
Microarray data
Microarray experiments should be MIAME compliant, please see www.mged.
org for more information. In addition, authors are encouraged to submit
the complete microarray data relating to that published in the manuscript to
an appropriate public database such as GEO (www.ncbi.nlm.nih.gov/geo/),
Array Express (www.ebi.ac.uk/arrayex-press/) or CIBEX (http://cibex.nig.
ac.jp/index.jsp).
Revised March 2009
Instructions to Authors
instructions for author.pdf
Editorial Board
Executive Committee Chairman:
Foo Yoo Liew (Glasgow, UK)
Deputies:
Marco Colonna (Saint Louis, USA)
Takashi Saito (Yokohama, Japan)
Members:
Alain Fischer (Paris, France)
Reinhold Förster (Hannover, Germany)
Ricardo Gazzinelli (Minas Gerais, Brazil)
Michel Goldman (Brussels, Belgium)
David Gray (Edinburgh, Scotland)
Rikard Holmdahl (Lund, Sweden)
Hans-Martin Jäck (Erlangen, Germany)
Sirpa Jalkanen (Turku, Finland)
Bernard Malissen (Marseille, France)
Alberto Mantovani (Milan, Italy)
Andrew McMichael (Oxford, UK)
Pamela Ohashi (Toronto, Canada)
Paola Ricciardi–Castagnoli (Singapore)
Editorial Board William Agace (Lund, Sweden)
Cezmi Akdis (Davos, Switzerland)
Graham Anderson (Birmingham, UK)
Francesco Annunziato (Florence, Italy)
Michael Beaven (Bethesda, USA)
Christian Bogdan (Freiburg, Germany)
Remy Bosselut (Bethesda, USA)
Margaret Callan (London, UK)
Xuetao Cao (Hangzhou, People's Republic of China)
Marco Cassatella (Verona, Italy)
Antonio Celada (Barcelona, Spain)
John Chan (New York, USA)
Lucienne Chatenoud (Paris, France)
Andrea Cooper (Saranac Lake, USA)
Pierre Coulie (Brussels, Belgium)
Gennaro De Libero (Basel, Switzerland)
James Di Santo (Paris, France)
Britta Engelhardt (Bern, Switzerland)
Anna Erdei (Budapest, Hungary)
Sidonia Fagarasan (Yokohama, Japan)
Kate Fitzgerald (Worcester, USA)
William Heath (Parkville, Australia)
Jules Hoffmann (Strasbourg, France)
Kristin Hogquist (Minnesota,USA)
Fang-Ping Huang (London, UK)
Tomohiro Kurosaki (Kanagawa, Japan)
Agnes Lehuen (Paris, France)
Fabienne Mackay (Darlinghurst, Australia)
Stephen Miller (Chicago,USA)
Paul Morgan (Cardiff, UK)
Alan Mowat (Glasgow, UK)
Luigi Notarangelo (Brescia, Italy)
Annette Oxenius (Zurich, Switzerland)
Manolis Pasparakis (Cologne, Germany)
Berent Prakken (Utrecht, The Netherlands)
David Raulet (Berkeley, USA)
Caetano Reis e Sousa (London, UK)
Maria Rescigno (Milan, Italy)
Pedro Romero (Lausanne, Switzerland)
Chris Rudd (Cambridge, UK)
David Sacks (Bethesda, USA)
Angela Santoni (Rome, Italy)
Megan Sykes (Boston, USA)
Yousuke Takahama (Tokushima, Japan)
Masafumi Takiguchi (Kumamoto, Japan)
Margot Thome (Epalinges, Switzerland)
David Woodland (New York, USA)
Maria Yazdanbakhsh (Leiden, The Netherlands)
Steven Ziegler (Seattle, USA)
Managing Editor Cate Livingstone
Assistant Editors Judy Peng
Susanne Viebahn
Administrator Sylvia Heider
|
|
|
|
